Monashee Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
TCM
O
CCA
SIMG
Monashee Investment Management's RGEN Position: Q3 2017 in Review
Monashee Investment Management sold out of Repligen (RGEN) in Q3 2017, closing a stake of 100,000 shares — an estimated $4.14M sold.
Monashee Investment Management first reported a position in RGEN in Q2 2017 and held it in 1 quarter. The position peaked at $4.14M in Q2 2017. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.
- Monashee Investment Management reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
- Monashee Investment Management sold 100,000 Repligen shares in Q3 2017, an estimated $4.14M.
- Monashee Investment Management first reported a position in Repligen in Q2 2017 and held it in 1 quarter.
- Monashee Investment Management's Repligen position peaked at $4.14M in Q2 2017.
- 190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.
Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.